ImportRefusal LogoImportRefusal

SEOULIN MEDICARE C

⚠️ Moderate Risk

FEI: 3014199274 • Hwaseong, Gyeonggi • SOUTH KOREA

FEI

FEI Number

3014199274

📍

Location

Hwaseong, Gyeonggi

🇰🇷
🏢

Address

4th Floor Seoulinglobal Center, 593-16 Dongtangiheung-Ro, Hwaseong, Gyeonggi, South Korea

Moderate Risk

FDA Import Risk Assessment

40.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
1
Unique Violations
8/5/2022
Latest Refusal
6/13/2022
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
22.3×30%
Recency
16.2×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

5083×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
8/5/2022
89ISAMASSAGER, THERAPEUTIC, ELECTRIC
508NO 510(K)
Division of Southeast Imports (DSEI)
6/27/2022
53LY99OTHER SKIN CARE PREPARATIONS, N.E.C.
508NO 510(K)
Division of Northeast Imports (DNEI)
6/13/2022
89ISAMASSAGER, THERAPEUTIC, ELECTRIC
508NO 510(K)
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is SEOULIN MEDICARE C's FDA import refusal history?

SEOULIN MEDICARE C (FEI: 3014199274) has 3 FDA import refusal record(s) in our database, spanning from 6/13/2022 to 8/5/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SEOULIN MEDICARE C's FEI number is 3014199274.

What types of violations has SEOULIN MEDICARE C received?

SEOULIN MEDICARE C has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about SEOULIN MEDICARE C come from?

All FDA import refusal data for SEOULIN MEDICARE C is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.